Merck outperforms S&P 500 with nearly 40% stock price increase
MRK Merck & Co Inc
$137.78 -3.90%
View chart & analysis → - 1Merck's stock price has recorded a nearly 40% increase so far in 2026.
- 2Merck achieved $8.6 billion in Keytruda sales in the third quarter.
- 3Merck currently shows a forward price-to-earnings ratio of 16.
So what's the key point?
Merck's stock price rose by 40%, significantly outperforming the market. The company saw strong results with key drug sales reaching $8.6 billion.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.